The Global Amblyopia Market Is Expected To Gain A Market Value Of USD 6.5 Billion By 2030 At A CAGR Of 4.2% From 2022-2030.

Amblyopia Market Overview:

Amblyopia is also known as lazy eye or blurry vision without noticeable changes. Reduced vision in one eye due to abnormal visual development at an early age, from birth to 7 years of age. Early diagnosis is important because early treatment is more effective. Treatment includes a glass eye patch.

 The amblyopia market is driven by factors such as the prevalence of hyperopia and myopia, refractive errors and cataracts globally. Additionally, favorable government funding for ophthalmic research fuels market growth in developing countries such as Mexico, India, and China. Increasing number of eye patches or spectacles at affordable cost fuels the growth of the amblyopia market. Additionally, increasing importance of ophthalmologists for regular check-ups to check the effectiveness of prescription eyeglasses in improving vision is estimated to drive expansion opportunities in the global amblyopia treatment market. However, lack of awareness about amblyopia treatment and lack of stringent government regulations for new treatment methods in developing countries are challenging the growth of the global amblyopia market. In addition, lack of availability of resources and technological advances restrain the market growth.

Amblyopia Market size, estimates and forecasts are provided in terms of sales volume (K units) and revenue (million USD), with historical and forecast data for the period 2017 to 2030, with 2022 being considered as the base year. This report segments the global Amblyopia Market in detail. Regional market sizes related to products by type, by application, and by player are also delivered. In estimating the size of the market, we took into account the impact of COVID-19 and the Russian-Ukraine war.

Key Market Updates:

• In March 2021, NovaSight applied for FDA 510(k) approval of CureSight for the treatment of amblyopia. The device trains the brain to use both eyes simultaneously while the user watches a video through the 3D glasses.
• In November 2020, EYEBAB entered into a distribution agreement with US company Vivid Vision. The new deal means that EYEBAB's accredited vision training platform is now available in Canadian and US distribution, and will be available globally across Vivid Vision's large professional network.
• In October, HOYA Vision Care announced a partnership with Orbis International, a global organization that advises, educates and inspires local eye care professionals to protect their vision within their group.

Major Market Segments Covered in Amblyopia Market Industry Research:

Market Key Players:
Amblyopia (Holding) Pty Ltd, Amblyotech Inc, Good-Lite Co, Vivid Vision Inc., Cooper Vision, Johnson & Johnson, Novartis AG, Carl Zeiss AG, HOYA Corporation, Krafty Eye Patches

By Type

• Strabismus amblyopia
• Refractive amblyopia
• Deprivation amblyopia
• Reverse amblyopia

By Diagnosis

• Visual acuity tests
• Photo screening
• Bruckner test
• Others

By Treatment

• Eye patches
• Atropine drops
• Glasses
• Video game
• Others

By Application:

• Hospitals & pharmacies
• Ophthalmic clinics

By Region:

North America is a promising region for the market. This region accounted for 37.6% of the market in 2019. The market in this region is expected to expand at a CAGR of ~3.1% during the forecast period. A significant market share in North America is attributed to the presence of advanced technologies in the healthcare industry. Additionally, the easy availability of resources supports the growth of major players and new entry into the market in the region. Increase in amblyopia cases in Europe is driving the growth of the market in this region. The high purchasing power of consumers in this region has a positive impact on market growth. The market in Asia Pacific is expected to grow at a significant rate during the forecast period owing to the increasing availability of amblyopia treatment technologies in the region. Additionally, increasing penetration of new companies through mergers and acquisitions boosts the market in the region.

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Denmark
• Finland
• Iceland
• Sweden
• Norway
• Benelux Union
• Belgium
• The Netherlands
• Luxembourg
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Indonesia
• Thailand
• Malaysia
• Singapore
• Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Significant Market Dynamics:

Drivers:

The major factors driving the revenue growth of the global amblyopia market are the increasing prevalence of eye diseases and growing child population worldwide. Additionally, rising healthcare spending in developed countries and improvements in healthcare facilities worldwide are also expected to drive market revenue growth. Health awareness campaigns and initiatives aimed at increasing people's awareness of various damaging disorders and treatments are expected to support market revenue growth during the forecast period.

Restraints:

Side effects associated with drugs used to treat amblyopia are one of the major factors expected to restrain market revenue growth during the forecast period. For example, Atropine sulphate eye drops used to treat amblyopia cause side effects such as blurred vision, eye pain, and impaired night vision.

In addition, factors such as high cost of treatment, stringent drug approval policies by national governments, failed surgeries or recurrence of conditions are expected to hinder market revenue growth to some extent.

Opportunity:

Developed healthcare infrastructure and growing use of modern technologies in R&D and treatment activities, along with increasing numbers of healthcare professionals in developed countries, will create lucrative revenue growth opportunities for emerging players.

Amblyopia Market report scope:

Key Takeaways from this Amblyopia Market Report

• Estimate Amblyopia Market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, applications and by different industry verticals.
• Understand the supply chain in depth on the value growth at each step, in order to optimize value and bring effectiveness in your processes.
• Know the different dynamics affecting the market - challenges, key driving factors and opportunities.
• Get a quick viewpoint on the Amblyopia Market entropy - M&A's, deals, partnerships, product launches of all key companies for the historical 5 years.
• Estimate the supply-demand gaps, import-export data and regulatory landscape for more than top 20 countries worldwide for the market.
• Get complete insights on your competitor performance - market shares, strategies, financial benchmarking, product benchmarking, SWOT and more.
• Study the sales and distribution channels over key geographies to improve top-line revenues.

Frequently Asked Questions-

What is the CAGR of Amblyopia Market?

The Amblyopia Market is growing at a CAGR of 4.2% During Forecast Period.

 What are the key types of Amblyopia Market?

Strabismus amblyopia, Refractive amblyopia, Deprivation amblyopia, Reverse amblyopia

What are the key applications of Amblyopia Market?

Hospitals & pharmacies, Ophthalmic clinics                                                             

Who are the key players in Amblyopia Market?

Amblyopia (Holding) Pty Ltd, Amblyotech Inc, Good-Lite Co, Vivid Vision Inc., Cooper Vision, Johnson & Johnson, Novartis AG, Carl Zeiss AG, HOYA Corporation, Krafty Eye Patches